FURIN and COVID-19: Docking studies of the mono-sartan EXP3174 with SARS-CoV-2 entry points (furin basic cleavage site and 3CLpro cleavage site) reveal strong interaction of the ARB tetrazole group with S-protein arginine residues inferring they are potential drugs for treating COVID-19 (Figure 11).